AFFY
Affymax, Inc. does not have significant operations. Previously, it was developing drugs to enhance the treatment of serious and often life-threatening conditions in the United States. The company was founded in 2001 and is based in New York, New York.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2014 Q2 | 0.19 | $42,000 | -$1M |
| 2014 Q1 | -0.04 | $0 | -$741,000 |
| 2013 Q4 | -38.32 | $0 | -$1M |
| 2013 Q3 | -0.05 | $332 | -$5M |
| 2013 Q2 | 0.41 | $525,000 | -$37M |
| 2013 Q1 | -0.72 | $844,000 | -$25M |
| 2012 Q4 | -1.85 | $15M | -$27M |
| 2012 Q3 | -0.68 | $14M | -$22M |